Indivior reported 152M in Stock for its fiscal semester ending in March of 2026.





Stock Change Date
AstraZeneca USD 6.93B 362M Jun/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Glaxosmithkline GBP 6.16B 39M Mar/2026
Hikma Pharmaceutical USD 1.11B 24M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
West Pharmaceutical Services USD 447.4M 5.2M Jun/2026